Beta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice
Ml. Salem et al., Beta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice, INT J IMMUN, 21(8), 1999, pp. 481-497
Mice treated with a contraceptive dose of beta-estradiol (E2) demonstrated
changes in their macrophage (M phi) number and functions. While E2 increase
d and decreased the M phi number in PBMC and PEC respectively, it enhanced
the in vitro phagocytosis of FITC-labeled beads by both cells. E2 treatment
also enhanced the phagocytic function of M phi as assessed by the in vivo
carbon clearance assay. In contrast, the in vitro intracellular killing fun
ction of adherent cells in peritoneal exudate cells (PEC) against Listeria
monocytogenes decreased after E2 treatment. In line with the decrease in th
e intracellular killing function, the E2-treated mice showed an impaired pr
otection against L. monocytogenes infection. To clarify the mechanism of th
e E2-mediated suppression of the protective response against L, monocytogen
es infection, we next analyzed the cytokine expression by PEC in E2-treated
L. monocytogenes-infected mice. On day 5 of the infection, the expression
of IL-12, TNF-alpha and IL-10 by adherent PEC from the E2-treated mice was
lower than that from the control-infected mice. The decrease in the cytokin
e expression by adherent PEC of E2-treated mice coincided with the decrease
of IFN-gamma expression, and the increase in the IL-4, IL-10 and TGF-beta
expressions by non-adherent PEG. These results revealed two aspects of the
effects of E2 on M phi. Even though E2 was found to enhance M phi phagocyto
sis, the anti-bacterial function was suppressed. This suppression may be me
diated by the inhibition of both IL-12 and TNF-alpha which play important r
oles in the protective response against intracellular bacteria. (C) 1999 In
ternational Society for Immunopharmacology. Published by Elsevier Science L
td. All rights reserved.